Ainos, Inc. (AIMD)
Market Cap | 13.96M |
Revenue (ttm) | 106,207 |
Net Income (ttm) | -14.83M |
Shares Out | 4.15M |
EPS (ttm) | -6.17 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 212,345 |
Open | 3.280 |
Previous Close | 3.250 |
Day's Range | 3.250 - 3.442 |
52-Week Range | 2.000 - 5.000 |
Beta | 2.21 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Aug 13, 2025 |
About AIMD
Ainos, Inc., a dual-platform AI and biotech company, focusing SmellTech, AI diagnostics, and immune therapeutics. Its AI Nose platform uses a smell language model to digitize scent into Smell IDs and turning invisible chemical signals into machine-readable data. The company is also giving AI for robotics, smart factories, senior care, and women’s health. In addition, it develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases, plus applications in animal health. The company was formerly known as Amarillo ... [Read more]
Financial Performance
In 2024, Ainos's revenue was $20,729, a decrease of -83.02% compared to the previous year's $122,112. Losses were -$14.86 million, 7.93% more than in 2023.
Financial StatementsNews

Ainos Reports Second Quarter 2025 Financial Results
1H 2025 Kicks Off AI Nose's Growing Commercial Momentum with First Senior Care Revenue and New Strategic Partnerships AI Nose 90-Day Roadmap to Power 2H 2025, with First Multi-Year $2.1M Order and Tra...

Ainos to Participate in Fireside Chat with Water Tower Research on August 20, 2025
SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 11, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent detection, today announced that it will pa...

Ainos Secures $2.1 Million Order With ASE for First Deployment of AI Nose in Semiconductor Manufacturing Setting
First Revenue-Generating Milestone for AI Nose Smell Language Model in High-Value Industrial Applications Ainos Building Commercial Momentum with Multi-Site Deployments Underway in Japan and Taiwan SA...

Ainos Receives TFDA Approval to Initiate Clinical Study of VELDONA for Primary Sjögren's Syndrome
Advancing a Novel, Side-Effect-Free Treatment for a Rare Yet Widely Underserved Autoimmune Disease SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 4, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("...

Water Tower Research Highlights Ainos' SmellTech Platform AI Nose as Foundational AI Innovation
AI Nose delivers accuracy and versatility, driving scalable growth across healthcare, industrial and robotics markets Technology, data moat, and strategic partnerships position Ainos for accelerated c...

Ainos and ugo Launch World's First AI Nose-Enabled Service Robot Pilots in Seven Sites Across Japan's Industrial Sector
Seven-Site Pilot Spanning Pharma, Facility Management, Energy and Utilities to Validate AI Nose as Next-Gen Industrial AI at Scale Robots Gain a New Sense: AI Nose Leverages Smell Language Model for S...

Ainos Regains Nasdaq Compliance, Sets 90-Day Roadmap to Scale AI Nose Platform in 2026
Commercial Momentum Accelerates with Partnerships to Drive AI-Powered Scent Intelligence for IndustrialAI and HealthcareAI SAN DIEGO, CALIFORNIA / ACCESS Newswire / July 16, 2025 / Ainos, Inc. (NASDAQ...

Water Tower Research Highlights Growing Momentum for Ainos' Scent-Tech Solutions and Industrial SmellTech Leadership with New High-Impact Partnerships
Ainos Pioneers SmellTech as the Next Sensory Frontier in Industrial AI 2H 2025 Industrial Pilots and Subscription Model Poised to Unlock Multi-Million Dollar Revenue Potential in 2026 SAN DIEGO, CALIF...

Ainos and Solomon Partner to Bring SmellTech Across Asia's Industrial Landscape
AI Nose and Smell Language Model Combine with Solomon's Vision AI to Power Multi-Sensory Automation Partnership Accelerates AI Scent Intelligence Deployment in Semiconductors, Robotics and More SAN DI...

Ainos Completes Stock Consolidation, Enters New Phase of Global Expansion and Technology Commercialization
Partners With ASE to Scale AI Nose Deployment and Set New Standard in Intelligent Sensing Achieves Strategic Inflection Point in 1H 2025 with Partnerships and Operational Breakthroughs SAN DIEGO, CALI...

Ainos and ASE Technology Holding Broaden Strategic Partnership to Target Deploy Up to 15,000 AI Nose Across Key Sites
Relationship Broadens Scope to Key ASE and SPIL Facilities with Multi-Phase Deployment Milestone Positions ASEH and Ainos as First-Mover in AI-Powered Scent Intelligence for the Semiconductor Industry...

Ainos Aligns Capital Structure With 2H 2025 Execution Roadmap; Announces Stock Consolidation
SAN DIEGO, CALIFORNIA / ACCESS Newswire / June 26, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it will implement a consolidation of its common stock ...

Ainos and Kenmec Launch Strategic Partnership to Deploy AI-Powered Scent Intelligence in Smart Factories Across Asia
AI Nose and SLM SmellTech platform enter scale-up phase targeting robotics, automation, and environmental sensing markets Kenmec and Ainos to show case AI Nose and SLM in Automation Taipei 2025 in Aug...

Water Tower Research Spotlights Ainos' Advances and Milestones in Digital Olfaction and Healthcare: Entering Inflection Point in 2H25
Ainos Hits Inflection Point with AI Nose Pilot Ramp in Senior Care, Robotics, and Semiconductors Key VELDONA® Human Clinical Studies Secure Taiwan Regulatory Greenlight, Accelerating Development SAN D...

Ainos Issues Mid-Year Update: Reaching Strategic Inflection in SmellTech and Immunotherapy
AI Nose Platform Advances Toward Scaled Pilot Programs Across Healthcare, Robotics, and Industrials VELDONA® Oral Interferon Receives Approval to Begin Human Trials in Taiwan SAN DIEGO, CA / ACCESS Ne...

Water Tower Research Highlights Ainos' AI Nose Accuracy Breakthrough in Elderly Care Monitoring: SmellTech Gets Smarter
AI Nose accuracy in elderly care improved to 85% with additional Smell ID training AI-friendly healthcare policies to provide tailwinds for commercial rollout SAN DIEGO, CALIFORNIA / ACCESS Newswire /...

Ainos AI Nose Improves Accuracy in Hygiene Monitoring To 85% from 80%
Accelerating Toward Commercial Rollout as AI Nose Solves Critical Gaps in Elder Care SAN DIEGO, CA / ACCESS Newswire / May 29, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos"), a leader in AI-...

Ainos Showcases Breakthrough AI Nose Technology at COMPUTEX 2025 with Japan's Robotics Partner
Robotic Smell Intelligence Goes Live at Asia's Premier AI Tech Stage SAN DIEGO, CA / ACCESS Newswire / May 22, 2025 / Ainos, Inc. (NASDAQ:AIMD)(Nasdaq:AIMDW) ("Ainos"), a pioneer in AI-driven scent di...

Ainos Reports Breakthrough Interim Results in VELDONA Clinical Trial for FCGS, Signaling New Era in Companion Animal Immunotherapy
Early results show steroid-free remission, opening pathway into $13B global pet dental health market VELDONA delivers consistent anti-inflammatory effects, strengthening Ainos' positioning in companio...

Water Tower Research Highlights Ainos' Significant Commercial Traction and Strategic Milestones Across Multiple Sectors
412% revenue growth reflects AI Nose sales in elderly care Expanding AI-driven scent tech beyond healthcare into robotics and industrial applications SAN DIEGO, CALIFORNIA / ACCESS Newswire / May 14, ...

Ainos Reports First Quarter 2025 Financial Results
Q1 revenues increased 412% year over year, driven by AI Nose products Delivers strong turnaround from gross loss to gross profit in Q1 AI Nose gains traction beyond healthcare with strategic partnersh...

Ainos Forms Partnership with ASE's Key Site to Power AI-Driven SmellTech in Semiconductor Smart Manufacturing
Expanding AI Nose's Commercial Opportunity for Smarter, Safer, and More Sustainable Factories SAN DIEGO, CALIFORNIA / ACCESS Newswire / April 30, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos...

Water Tower Research Spotlights Ainos' Smell Integration in Humanoid Robot - AI Smelltech is Progressing Rapidly
Robotic smelltech by AI Nose moves from concept to integration in weeks Partnership fast-tracks robotic smell integration as global service robotics market nears $40.6B, Japan $1.2B SAN DIEGO, CALIFOR...

Ainos and ugo Complete First Robotic Smell Integration in Japan
Milestone Ignites a New Era of Smell-Enabled Robotics Installs AI Nose in ugo Robot; Real-World Pilots to Begin in Weeks SAN DIEGO, CA / ACCESS Newswire / April 21, 2025 / Ainos, Inc. (Nasdaq:AIMD)(Na...

Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjögren's Syndrome in Taiwan
Dual Trials Accelerate VELDONA® Toward Rare Disease Market Entry Bridging Strategy Aims to Fast-Track U.S. Regulatory Approvals SAN DIEGO, CALIFORNIA / ACCESS Newswire / April 14, 2025 / Ainos, Inc. (...